Recent Authoritative COPD Guidelines
Based on the available evidence, the most recent authoritative guidelines on COPD published between 2016-2026 include approximately 8-10 major international and national guidelines, with publication dates ranging from 2016 to 2026.
Identified Guidelines and Publication Dates
Most Recent Guidelines (2022-2026)
Japanese Respiratory Society (JRS) Guidelines - 7th Edition (March 2026) 1
- Incorporates GOLD 2023 etiotype classification
- Addresses Japan-specific patient characteristics including lean body composition and high ACO prevalence
- Includes 22 clinical questions (15 retained, 7 new)
Chinese Practice Guideline for COPD - 2026 Revision (planned publication 2026) 2
- Registered at International Practice Guidelines Registry Platform (PREPARE-2026CN522)
- Jointly developed by Chinese Thoracic Society and Chinese Association of Chest Physicians
- Addresses 22 clinical questions using GRADE methodology
Spanish COPD Guidelines (GesEPOC) - 2025 Update 3
- Published in Archivos de Bronconeumología
- Uses GRADE methodology for 12 PICO questions
- Introduces phenotype-based treatment approach (non-exacerbator, eosinophilic exacerbator, non-eosinophilic exacerbator)
New Zealand COPD Guidelines - 2025 Update 4
- Published by Asthma and Respiratory Foundation NZ
- Tailored to Aotearoa New Zealand clinical context
National Implementation Guideline for COPD in Primary Care (China) - 2025 5
- Focuses on primary healthcare implementation
- Integrates traditional Chinese medicine approaches
Canadian Thoracic Society (CTS) Guideline - 2023 6
- Published in Chest
- Focuses on pharmacotherapy in stable COPD
- Updates 2019 recommendations with strong evidence for LAMA/LABA dual therapy
COPD-X Australian Guidelines - 2022 Update (Version 2.65) 7
- Published by Lung Foundation Australia and Thoracic Society of Australia and New Zealand
- Quarterly updates provided
- Contains 26 recommendations across five domains
Earlier Guidelines (2011-2020)
British Thoracic Society Guideline for Long-term Macrolides - 2020 8
- Published in Thorax
- Specialized guideline addressing macrolide therapy in respiratory disease including COPD
European National Guidelines Review - 2016 9
- Published in European Respiratory Journal
- Reviewed guidelines from 11 European countries (Czech Republic, England/Wales, Finland, France, Germany, Italy, Poland, Portugal, Russia, Spain, Sweden)
- Publication dates of reviewed guidelines ranged from 2007 (Germany) to 2015 (Finland)
Unified Guideline from ACP/ACCP/ATS/ERS - 2011 10
- Published in Chest
- Multi-society collaborative guideline
- Updated previous ACP document from 2007
Important Context
The GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines, while referenced in multiple sources 11, are not explicitly detailed in the provided evidence but represent the most widely recognized international framework that many national guidelines reference or adapt.
The evidence demonstrates significant geographic variation in guideline development, with Asian-Pacific guidelines (Japan, China, Australia, New Zealand) showing the most recent updates (2022-2026), reflecting evolving understanding of regional patient characteristics and treatment responses 1, 3.